John A. Lewicki, EVP & Chief Scientific Officer at OncoMed Pharmaceuticals Inc (OMED), sold 4,000 shares at $23.75 ($95K) on 2014-07-01, disclosed to the SEC on 2014-07-03.
Scheduled sale ($95k) by EVP & Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $23.75 | 3,296 | $78K | 82.0% |
| 2 | $24.36 | 704 | $17K | 18.0% |
| Total | $23.86 avg | 4,000 | $95K | 100% |
| Filing → |
| OMED | SELL | 2018-10-11 | $2K | — | Filing → |
| OMED | SELL | 2018-10-10 | $5K | — | Filing → |
| OMED | SELL | 2018-04-26 | $12K | — | Filing → |